Public Citizen Sues FDA To Get Parecoxib “Not Approvable” Letter
This article was originally published in The Pink Sheet Daily
Public Citizen is suing FDA to get a copy of the July 2001 "not approvable" letter for Pfizer's COX-2 inhibitor parecoxib
You may also be interested in...
Obamacare repeal has been replaced by rebrand as Trump administration plans to use ACA’s Medicare demonstration powers to send discount cards to seniors, one of a slew of health care announcements that include Rx importation, pre-existing conditions, insulin and EpiPens.
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.